Governing the Metaverse in Healthcare: Regulation, Reimbursement and Health Equity in Immersive Care

Growth of the metaverse in healthcare market depends less on the maturity of headsets than on the institutions that decide which immersive tools count as medicine, who pays for them and who can reach them. This study examines that proposition through technology governance and health equity, combining the forecast of Next Move Strategy Consulting (2025), which values the global market at USD 18.91 billion in 2025 and USD 100.34 billion by 2030, with regulatory records, public statistics, company disclosures and peer-reviewed trials from 2025 and 2026. Three findings emerge. First, regulatory authorization is concentrated in surgical visualization and neurological navigation: 118 of the 120 entries on the United States regulator's augmented and virtual reality device list were cleared through the 510(k) route, while trial evidence for therapeutic immersive care remains mixed. Second, payment and data rules, including the 2026 Medicare digital therapeutic codes and the European Health Data Space, move more slowly than device clearance. Third, the settings with the deepest workforce shortages and connectivity gaps are the least positioned to capture early value. Investors and policy makers should treat evidence generation, payment alignment and infrastructure as the binding constraints on growth, and hardware supply as a secondary risk.

Authors

Publication Details

Journal
Knowledge Commons Works (Michigan State University)
Published
2026-11-19
DOI
https://doi.org/10.17613/7sa8d-yay31
Primary Topic
Healthcare Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Governing the Metaverse in Healthcare: Regulation, Reimbursement and Health Equity in Immersive Care

Sanyukta Deb
Knowledge Commons Works (Michigan State University)
Healthcare Regulation
article

Governing the Metaverse in Healthcare: Regulation, Reimbursement and Health Equity in Immersive Care

Sanyukta Deb
article en

Abstract

Growth of the metaverse in healthcare market depends less on the maturity of headsets than on the institutions that decide which immersive tools count as medicine, who pays for them and who can reach them. This study examines that proposition through technology governance and health equity, combining the forecast of Next Move Strategy Consulting (2025), which values the global market at USD 18.91 billion in 2025 and USD 100.34 billion by 2030, with regulatory records, public statistics, company disclosures and peer-reviewed trials from 2025 and 2026. Three findings emerge. First, regulatory authorization is concentrated in surgical visualization and neurological navigation: 118 of the 120 entries on the United States regulator's augmented and virtual reality device list were cleared through the 510(k) route, while trial evidence for therapeutic immersive care remains mixed. Second, payment and data rules, including the 2026 Medicare digital therapeutic codes and the European Health Data Space, move more slowly than device clearance. Third, the settings with the deepest workforce shortages and connectivity gaps are the least positioned to capture early value. Investors and policy makers should treat evidence generation, payment alignment and infrastructure as the binding constraints on growth, and hardware supply as a secondary risk.

Knowledge Commons Works (Michigan State University)
Healthcare Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon